You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphocytopenia

Showing 1 - 25 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)

Recruiting
  • Idiopathic CD4 T Cell Lymphocytopenia
  • Gardasil 9
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 10, 2023

Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • Idiopathic CD4-Positive
  • T-Lymphocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Natural History of Idiopathic CD4+ Lymphocytopenia

Recruiting
  • Idiopathic CD4+ Lymphocytopenia
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Human Immunodeficiency Virus (HIV) Testing

    Completed
    • HIV Seropositivity
    • CD4+ T Lymphocytopenia
    • Medical record review
    • Jena, Thuringia, Germany
      University Hospital Jena
    Aug 30, 2021

    Covid19 Trial in Providence (Thymalfasin)

    Recruiting
    • Covid19
    • Providence, Rhode Island
      The Miriam Hospital
    Sep 14, 2021

    COVID-19, Lymphocytopenia Trial in Brazil (Interleukin-7, PLACEBO)

    Terminated
    • COVID-19
    • Lymphocytopenia
    • Porto Alegre, RIO Grande DO SUL, Brazil
    • +5 more
    Mar 30, 2022

    COVID-19, Lymphocytopenia Trial in United Kingdom (Interleukin-7, Placebos)

    Terminated
    • COVID-19
    • Lymphocytopenia
    • Birmingham, United Kingdom
    • +12 more
    Mar 30, 2022

    HIV-1-infection, CD4+ T Lymphocytopenia, Immune Deficiency Trial in Ciudad de México (Pyridostigmine Bromide, Placebo)

    Suspended
    • HIV-1-infection
    • +3 more
    • Pyridostigmine Bromide
    • Placebo
    • Ciudad de México, Tlalpan, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Apr 8, 2020

    Acute Respiratory Distress Syndrome Trial (Intravenous glucocorticoid therapy)

    Not yet recruiting
    • Acute Respiratory Distress Syndrome
    • Intravenous glucocorticoid therapy
    • (no location specified)
    May 30, 2022

    Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

    Completed
    • Urinary Bladder Cancer
    • +4 more
    • Neutrophil to lymphocyte ratio
    • Cairo, Egypt
      Ain Shams university
    Jul 15, 2023

    Cryptococcosis in Previously Healthy Adults

    Recruiting
    • Cryptococcus
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Hematological Disorders in Covid 19 Patients

      Not yet recruiting
      • Hematological Abnormalities in covid19
        • (no location specified)
        Jan 6, 2022

        Double-dose Furmonertinib in Treatment of Slow

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • +3 more
        • (no location specified)
        Oct 31, 2023

        Neuroblastoma, Medulloblastoma Trial in United States (TPI 287)

        Terminated
        Has Results
        • Neuroblastoma
        • Medulloblastoma
        • TPI 287
        • San Diego, California
        • +7 more
        Apr 20, 2022

        Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)

        Not yet recruiting
        • Pancreatic Neoplasms
        • Shanghai, China
          Fudan University ShangHai Cancer Center
        Jul 31, 2023

        COVID-19 After Autologous Hematopoietic Stem Cell

        Completed
        • Covid19
        • +4 more
        • Autologous stem cell transplantation
        • Uppsala, Sweden
          Uppsala Universitet
        Feb 7, 2022

        COVID-19 Trial in Shanghai (Hymecromone tablets, Placebo)

        Recruiting
        • COVID-19
        • Hymecromone tablets
        • Placebo
        • Shanghai, Shanghai, China
          Zhong Shan Hospital affiliated to Fudan University
        Jun 7, 2022

        Glioblastoma Trial in Pittsburgh (Radiation Therapy, Temozolomide Oral Product)

        Recruiting
        • Glioblastoma
        • Radiation Therapy
        • Temozolomide Oral Product
        • Pittsburgh, Pennsylvania
          University of Pittsburgh Medical Center, Radiation Oncology
        Jan 6, 2022

        Sepsis, Severe Trial in France, United States (CYT107, Placebos)

        Terminated
        • Sepsis, Severe
        • CYT107
        • Placebos
        • Gainesville, Florida
        • +9 more
        Oct 19, 2021

        Leukemia, Lymphocytic, Chronic Trial run by the NCI (rhIL-15, Obinutuzumab)

        Terminated
        Has Results
        • Leukemia
        • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Mar 11, 2022

        Idiopathic CD4 Lymphocytopenia

        Completed
        • Idiopathic CD4 Lymphocytopenia
        • Constitution of a biobank of frozen cells, plasma and serum samples
        • Genetic study
        • Paris, France
          Cochin Hospital
        Mar 16, 2018

        Neuroblastoma Trial in United States (TPI 287, Temozolomide, Irinotecan)

        Terminated
        Has Results
        • Neuroblastoma
        • TPI 287
        • +2 more
        • Phoenix, Arizona
        • +7 more
        Apr 20, 2022

        Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)

        Active, not recruiting
        • Hepatocellular Carcinoma
        • Radioembolization using Holmium-166
        • Brussels, Anderlecht, Belgium
          Hôpital Universitaire Erasme, ULB
        Dec 7, 2022

        Breast Cancer Trial in Houston (Ra-223 dichloride, Denosumab, Hormone Therapy)

        Completed
        Has Results
        • Breast Cancer
        • Ra-223 dichloride
        • +2 more
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Oct 5, 2021

        Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

        Active, not recruiting
        Has Results
        • Respiratory System Agents
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jan 20, 2022